Alkem Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.
Alkem Laboratories Limited, with Security Code 539523, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | 23,653.70 | 3,249.71 | 24,491.60 | 27.18 | -6,831.00 | 837.90 | -691.00 | 3,890.11 |
2023-10-01 | 2023-12-31 | 24,945.90 | 5,042.30 | 25,902.50 | 42.17 | -5,132.00 | 956.60 | -581.20 | 5,343.80 |
2023-10-01 | 2023-12-31 | 33,238.70 | 6,042.80 | 34,175.10 | 49.76 | -7,395.90 | 936.40 | -695.60 | 6,549.00 |
2023-07-01 | 2023-09-30 | 26,345.90 | 6,465.10 | 26,964.30 | 54.07 | -5,846.40 | 618.40 | -590.20 | 6,387.20 |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 11% |
3 Years: | 11% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | 15% |
5 Years: | 18% |
3 Years: | 3% |
TTM: | 57% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 23% |
3 Years: | 15% |
1 Year: | 41% |
Compounded Sales Growth | |
---|---|
10 Years: | 15% |
5 Years: | 11% |
3 Years: | 13% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | 16% |
5 Years: | 20% |
3 Years: | 7% |
TTM: | 77% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 23% |
3 Years: | 15% |
1 Year: | 41% |